ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.320,96
0,00%
S&P 500
5.631,22
0,28%
US Dollar vs BRL
5,42711
-0,39%
Bitcoin
64.148,61
-1,08%
Brent Oil
83,005
-1,58%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Avid Bioservices Inc (CDMOP)

  7. Avid Bioservices Inc (CDMOP) Notícias

CDMOP

Avid Bioservices (CDMOP)

Avid Bioservices Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP
DataHoraFonteTítuloCódigoCompanhia
20/02/201818:05GlobeNewswire Inc.Avid Bioservices Announces Closing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
15/02/201808:00GlobeNewswire Inc.Avid Bioservices Announces Pricing of Public Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
14/02/201819:02GlobeNewswire Inc.Avid Bioservices Announces Proposed Offering of Common StockNASDAQ:CDMOPAvid Bioservices Inc
12/02/201811:05GlobeNewswire Inc.Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including...NASDAQ:CDMOPAvid Bioservices Inc
23/01/201811:05GlobeNewswire Inc.Avid Bioservices to Present at NobleCon14NASDAQ:CDMOPAvid Bioservices Inc
05/01/201811:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development a...NASDAQ:CDMOPAvid Bioservices Inc
02/01/201811:05GlobeNewswire Inc.Peregrine Pharmaceuticals to Present at Biotech Showcase 2018NASDAQ:CDMOPAvid Bioservices Inc
26/12/201719:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CDMOPAvid Bioservices Inc
26/12/201711:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive OfficerNASDAQ:CDMOPAvid Bioservices Inc
11/12/201719:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CDMOPAvid Bioservices Inc
11/12/201719:05GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
07/12/201719:58Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CDMOPAvid Bioservices Inc
07/12/201719:57Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CDMOPAvid Bioservices Inc
07/12/201719:05GlobeNewswire Inc.Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred StockNASDAQ:CDMOPAvid Bioservices Inc
04/12/201719:05GlobeNewswire Inc.Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 1...NASDAQ:CDMOPAvid Bioservices Inc
29/11/201711:05GlobeNewswire Inc.Avid Bioservices Announces Appointment of Tracy Kinjerski as Vice President of Business OperationsNASDAQ:CDMOPAvid Bioservices Inc
28/11/201719:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CDMOPAvid Bioservices Inc
28/11/201711:05GlobeNewswire Inc.Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement AgreementNASDAQ:CDMOPAvid Bioservices Inc
13/11/201717:32Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CDMOPAvid Bioservices Inc
13/11/201711:05GlobeNewswire Inc.Peregrine Announces Date of 2017 Annual Meeting of StockholdersNASDAQ:CDMOPAvid Bioservices Inc
01/11/201717:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CDMOPAvid Bioservices Inc
30/10/201718:01Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:CDMOPAvid Bioservices Inc
24/10/201719:24Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CDMOPAvid Bioservices Inc
24/10/201710:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid BioservicesNASDAQ:CDMOPAvid Bioservices Inc
19/10/201710:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid BioservicesNASDAQ:CDMOPAvid Bioservices Inc
25/09/201709:05GlobeNewswire Inc.Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius® 2,000-Lit...NASDAQ:CDMOPAvid Bioservices Inc
19/09/201709:05GlobeNewswire Inc.Avid Bioservices to Exhibit at 2017 BioProcess International Conference & ExhibitionNASDAQ:CDMOPAvid Bioservices Inc
11/09/201717:05GlobeNewswire Inc.Peregrine Pharmaceuticals Reports Financial Results for First Quarter of Fiscal Year 2018 and Recent DevelopmentsNASDAQ:CDMOPAvid Bioservices Inc
11/09/201709:05GlobeNewswire Inc.Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D. as President of Avid BioservicesNASDAQ:CDMOPAvid Bioservices Inc
07/09/201709:10GlobeNewswire Inc.Peregrine Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combinati...NASDAQ:CDMOPAvid Bioservices Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CDMOP

Seu Histórico Recente

BIT
P1Y201
NLBNPIT1Y201 20240920 3.2
BOV
BRSR6
BANRISUL PNB
NYSE
ARLO
Arlo Technologies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados